Sumitomo Seika Chemicals Company,Limited. (4008) FY2027 Q1

Quick View

Executive Summary

The first quarter of the fiscal year ending March 2027 saw increases in both revenue and profit, with multi-stage margin improvement progressing against a backdrop of price revisions and stable costs. Revenue was ¥40.40B (+13.6% YoY), Operating Income was ¥3.45B (+47.5%), Ordinary Income was ¥4.31B (+168.5%), and Net Income was ¥3.26B (+212.2%). While positive operating leverage emerged as the increase in SG&A expenses (+11.8%) remained below revenue growth (+13.6%), temporary factors also made a significant contribution to the substantial increases in Ordinary Income and Net Income, including ¥0.37B in foreign exchange gains and ¥0.55B in extraordinary income, including gains on the sale of investment securities.

Factors Driving Earnings Changes

【Revenue】Revenue was ¥40.40B, an increase of +13.6% YoY. The core Superabsorbent Polymers segment led growth with revenue of ¥31.87B (78.9% of total revenue, +14.1% YoY), while the Functional Materials segment also contributed to the increase with revenue of ¥8.48B (21.0% of total revenue, +11.9% YoY). Both segments recorded revenue growth, indicating improvement driven by both price revisions and volume.

【Profit and Loss】Operating Income was ¥3.45B (+47.5% YoY). Gross margin improved to 22.7% (+1.7pt YoY), while the Operating Income margin improved to 8.5% (+2.0pt) despite an SG&A expense ratio of 14.2%. In non-operating items, non-operating income of ¥0.95B, including ¥0.37B in foreign exchange gains, contributed to an increase in Ordinary Income to ¥4.31B (+168.5%). In addition, extraordinary income of ¥0.55B, primarily gains on the sale of investment securities, lifted Profit Before Tax to ¥4.81B. After deducting income taxes and other taxes of ¥1.55B (effective tax rate: 32.2%), Net Income was ¥3.26B (+212.2% YoY); the difference between Ordinary Income and Net Income was primarily attributable to the tax burden. Both revenue and profit exceeded the previous year, reflecting a combination of improved core profitability and temporary non-operating and extraordinary gains and losses.

Segment Analysis

The Superabsorbent Polymers segment is the core business, with revenue of ¥31.87B (+14.1% YoY), Operating Income of ¥2.70B (+26.7%), and an Operating Income margin of 8.5%, accounting for 78.9% of revenue and 78.3% of profit. The Functional Materials segment recorded revenue of ¥8.48B (+11.9% YoY) and Operating Income of ¥0.74B, a substantial increase of +297.3% YoY, resulting in a margin of 8.8%, slightly exceeding that of Superabsorbent Polymers. This substantial increase in profit reflected the base effect from an impairment loss of ¥0.19B recognized for manufacturing equipment at the Chiba Plant in the same period of the previous year. Although an impairment loss of ¥0.03B was also recorded at the same plant during the current period, the amount was smaller and profitability improved. The Other segment recorded revenue of ¥0.27B (+2.2% YoY) and Operating Income of ¥0.006B (-66.7% YoY), representing a decline in profit, although its scale is small relative to the total. The structure in which a single segment accounts for the majority of profit indicates high sensitivity to demand and price fluctuations in that business.

Key Financial Indicators

【Profitability】The Operating Income margin was 8.5%, improving from 6.6% in the same period of the previous year, while the Net Income margin improved substantially to 8.1% from 2.9%. R&D expenses as a percentage of revenue were 2.2% (¥0.89B). 【Cash Quality】Inventories rose significantly to ¥28.98B, an increase of +40.0% YoY, growing faster than revenue (+13.6%). Cash and deposits were ¥15.16B, down from ¥18.22B in the same period of the previous year, suggesting that increased working capital may have raised funding requirements. 【Investment Efficiency】ROE was 3.1% (calculated simply based on quarterly profit and net assets at the end of the period), while ROA was 2.0% (Net Income/total assets). Total asset turnover remained low, with higher inventories weighing on asset efficiency. 【Financial Soundness】The Equity Ratio was 65.8%, slightly down from 67.8% in the same period of the previous year. Liquidity remained ample, with a current ratio of 232.4% and a quick ratio of 155.4%; however, short-term borrowings surged to ¥9.74B, an increase of +227.1% YoY. The ratio of interest-bearing debt (total short- and long-term borrowings of ¥24.24B) to net assets was 23.0%. The total liabilities-to-net-assets ratio (equivalent to D/E) was 0.52x, while interest coverage, measured as EBIT divided by interest expense, was approximately 46.6x, indicating robust debt-servicing capacity.

Cash Flow Analysis

As cash flow statement data has not been disclosed, funding trends are analyzed based on changes in the balance sheet. Cash and deposits declined to ¥15.16B from ¥18.22B in the same period of the previous year, while inventories increased from ¥20.70B to ¥28.98B, or +40.0%, during the period, suggesting that inventory buildup was the primary use of funds. In response to this increased working capital requirement, short-term borrowings surged from ¥2.98B to ¥9.74B, or +227.1%, indicating that part of the inventory buildup was financed through short-term funding. Meanwhile, treasury stock declined substantially from a negative balance of ¥4.20B to ¥0.35B, suggesting the possibility of cash generation through disposal or other transactions. The simultaneous decline in cash and deposits and increase in short-term liabilities indicates that normalization of inventory turnover will be a key focus in evaluating the Company’s cash-generation capacity from operating activities.

Earnings Quality

Recurring earnings improvement has been supported by successive increases in gross and Operating Income margins, suggesting that the improvement in core business margins is structural in nature. At the same time, temporary factors made a significant contribution to the increase in Ordinary Income and Net Income: foreign exchange gains accounted for ¥0.37B of non-operating income of ¥0.95B, equivalent to approximately 10.8% of Operating Income. In addition, extraordinary income of ¥0.55B was primarily composed of gains on the sale of investment securities, reaching approximately 16.8% of Net Income of ¥3.26B and therefore representing a non-negligible temporary factor. Extraordinary losses remained limited at a total of ¥0.05B, comprising an impairment loss of ¥0.03B and a loss on disposal of fixed assets of ¥0.02B. The structure in which Net Income was ¥3.26B after deducting income taxes and other taxes of ¥1.55B (effective tax rate: 32.2%) from Profit Before Tax of ¥4.81B indicates that the difference between Ordinary Income and Net Income was primarily attributable to the tax burden. Accordingly, while the improvement in core profitability appears to have a strong sustainable aspect, determining the level of core earnings excluding temporary foreign exchange gains and gains on the sale of investment securities will be important in assessing future earnings quality.

Earnings Forecast and Guidance

The Full-Year progress rates were 24.5% for revenue (¥40.40B against ¥165.00B), 31.4% for Operating Income (¥3.45B against ¥11.00B), 38.5% for Ordinary Income (¥4.31B against ¥11.20B), and 40.8% for Net Income (¥3.26B against the assumed ¥8.00B), indicating progress ahead of the simple quarterly allocation benchmark of 25%. The particularly high progress rates for Ordinary Income and Net Income appear to reflect contributions from the aforementioned temporary factors, namely foreign exchange gains and gains on the sale of investment securities. The Company’s Full-Year forecast calls for revenue growth of +11.2% YoY, while projecting declines of -24.0% in Operating Income and -26.6% in Ordinary Income, contrasting with the substantial profit increases recorded in Q1. This Company plan is consistent with a conservative incorporation of potential headwinds in the second half, such as raw material prices and inventory adjustment costs, and suggests that the Full-Year profit level may normalize relative to Q1.

Shareholder Returns

The Full-Year dividend forecast is ¥70.00 per share, representing a Payout Ratio of 56.2% against forecast Full-Year EPS of ¥124.46. During the current quarter, the Company revised its dividend forecast and announced a change in its dividend policy involving the introduction of a DOE (dividend on equity) approach. A 5-for-1 stock split of common shares was implemented on April 1, 2026, and it should be noted that the current-period dividend amounts are stated on an actual pre-split basis (on a post-split equivalent basis, they are said to correspond to ¥20 for the interim dividend, ¥24 for the year-end dividend, and ¥44 for the full year). The dividend for the same period of the previous year was ¥100 on a pre-split basis, so the impact of the stock split must be considered in making a simple comparison. A Payout Ratio of 56.2% appears to be within an acceptable range in light of cash and deposits of ¥15.16B and the Company’s low-leverage financial structure.

Risk Factors

1. Segment concentration risk: The Superabsorbent Polymers segment accounts for 78.9% of revenue and 78.3% of Operating Income, resulting in high sensitivity of overall earnings to price and demand fluctuations in this business. Trends in acrylic acid prices, the raw material, and demand for disposable diapers and hygiene materials may affect earnings.

2. Working capital risk: Inventories increased +40.0% YoY, substantially faster than revenue growth (+13.6%), and stagnant inventory could weigh on cash-generation capacity. Short-term borrowings also surged by +227.1% YoY in response, making normalization of working capital an issue going forward.

3. Foreign exchange sensitivity: Foreign exchange gains of ¥0.37B included in non-operating income were equivalent to approximately 10.8% of Operating Income, indicating a moderate impact of foreign exchange movements on earnings. These gains are temporary in nature and are expected to normalize over the Full Year.

Industry Benchmark (Reference; Compiled by the Company)

Profitability and Returns

The Operating Income margin is in line with the industry median, while the Net Income margin exceeds the median, with non-operating and extraordinary gains and losses, including temporary factors, lifting the Net Income level.

Growth and Capital Efficiency

Revenue growth is substantially above the industry median and is close to the upper bound of the IQR.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. Gross margin and Operating Income margin improved in successive stages against a backdrop of price revisions and stable costs, with positive operating leverage emerging as the increase in SG&A expenses (+11.8%) remained below revenue growth (+13.6%). The Functional Materials segment recorded a substantial +297.3% increase in Operating Income, partly due to the base effect from the impairment loss recognized in the previous year, contributing to an overall strengthening of the earnings profile.

2. Although the Full-Year progress rate for Net Income is high at 40.8%, the contribution of temporary factors—including foreign exchange gains equivalent to approximately 10.8% of Operating Income and extraordinary income primarily comprising gains on the sale of investment securities equivalent to approximately 16.8% of Net Income—should be considered when evaluating the Full-Year profit level.

3. Inventories and short-term borrowings increased simultaneously by +40.0% and +227.1%, respectively. Although liquidity remains ample, working capital efficiency has declined from the same period of the previous year. Normalization of inventory turnover will be a key monitoring point in evaluating future cash-generation capacity.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥1,531–¥1,618 at ±1% for the cost of equity capital, and ¥1,571–¥1,575 at ±0.1 for ω.

Notes:

• Because Net Income progress against the Full-Year forecast (41%) exceeds the standard benchmark (25%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of schedule tend to exceed forecasts; the adjustment may be excessive for businesses with strong seasonality).
• Because forecast ROE is below the cost of equity capital, the theoretical value is below book value per share.
• Net assets at the end of the quarter are used (there is a timing discrepancy relative to the Full-Year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat above the appropriate level.

(Calculation model: residual income model / interest-rate reference month: 2026-07 / this value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a strong earnings quarter, with revenue growth translating into materially faster operating and net-profit growth. Revenue increased 13.6% YoY to ¥40.40bn. Operating income rose 47.5% to ¥3.45bn, lifting the operating margin to 8.5% from 6.6%, an expansion of approximately 195bp. Gross profit increased to ¥9.18bn and the gross margin improved to 22.7% from 21.0%, or about 170bp. SG&A rose 11.8% YoY to ¥5.73bn, below revenue growth, demonstrating positive operating leverage. Ordinary income surged 168.5% to ¥4.32bn, supported by ¥0.37bn of foreign-exchange gains and ¥0.19bn of subsidy income. Profit before tax increased 242.3% to ¥4.81bn. Net income grew 212.2% to ¥3.26bn, and net margin rose to 8.1% from 2.9%, an expansion of approximately 513bp. Net income also benefited from a ¥0.55bn gain on sale of investment securities, equivalent to 16.8% of quarterly net income, reducing the repeatability of reported bottom-line growth. The impairment loss in Functional Materials fell to ¥0.03bn from ¥0.19bn a year earlier, also aiding the YoY comparison. Absorbent Resins remained the core business by operating-profit contribution, generating ¥2.70bn, or about 78% of consolidated operating income. Functional Materials delivered the strongest incremental profitability improvement, with segment profit nearly quadrupling to ¥0.74bn. The annualized DuPont ROE was 12.4%, within the good 10-15% range, supported by an 8.1% net margin, 1.009x annualized asset turnover, and 1.52x financial leverage. Liquidity remains robust, with a 232.4% current ratio and a 155.4% quick ratio. However, the ¥8.27bn YoY rise in inventories, elevated receivable and inventory days, and a 123-day annualized cash conversion cycle require close monitoring as sales expand. The full-year plan implies Q1 revenue progress broadly in line with seasonality, while profit progress is ahead of the normal first-quarter run rate. The revised FY2027 dividend forecast of ¥70 per share implies a 56.2% payout ratio against forecast EPS of ¥124.46, which appears earnings-covered. The central forward issue is whether margin gains and segment recovery can offset the FY2027 full-year forecast for lower operating and ordinary income despite projected revenue growth.

Profitability Analysis

Annualized DuPont ROE of 12.4% decomposes into an 8.1% net profit margin, 1.009x annualized asset turnover, and 1.52x financial leverage. The main driver of the quarter's improvement was profitability: operating margin expanded by approximately 195bp YoY to 8.5%, while gross margin expanded by approximately 170bp to 22.7%. This indicates that the ¥4.83bn revenue increase was converted into disproportionately higher gross profit, while SG&A growth of 11.8% remained below revenue growth of 13.6%. Absorbent Resins sales increased 14.1% to ¥31.87bn and segment profit increased 26.7% to ¥2.70bn; its segment margin improved 84bp to 8.5%. Functional Materials sales rose 11.9% to ¥8.47bn, but segment profit increased to ¥0.74bn from ¥0.19bn, lifting segment margin to 8.8% from 2.5%. The Functional Materials rebound was aided by a sharply lower impairment charge, at ¥0.03bn versus ¥0.19bn in the prior-year quarter, so not all of its net-income improvement should be treated as recurring. Other businesses generated ¥0.06bn of segment profit, down from ¥0.18bn, and remained immaterial to consolidated profitability. R&D expense increased 24.9% YoY to ¥0.89bn, outpacing revenue growth, but its 2.2% intensity remains below the 3% alert threshold. Interest coverage of 46.65x indicates that interest expense is not constraining profitability. The effective tax rate was 32.2%, producing a 0.678 tax burden; this is moderately below the 0.70 reference level but is not a material impairment to earnings capacity. The interest burden exceeded 1.0x because earnings before tax benefited from non-operating income and extraordinary gains relative to operating income, rather than because of leverage.

Growth Assessment

Revenue growth was broad across the two reportable segments. Absorbent Resins, which represents approximately 79% of external segment sales, remains the principal source of revenue growth and earnings. Functional Materials contributed a smaller but substantially stronger profit rebound, making it the key source of incremental margin expansion. Consolidated Q1 revenue reached 24.5% of the ¥165.0bn full-year forecast, essentially in line with the standard 25% first-quarter progress rate. Operating income reached 31.4% of the ¥11.0bn full-year forecast, 6.4 percentage points ahead of the standard pace. Ordinary income reached 38.5% of the ¥11.2bn forecast, 13.5 percentage points ahead of the standard pace. Net income reached 40.8% of the ¥8.0bn forecast, 15.8 percentage points above the standard first-quarter pace. The stronger ordinary and net-income progress partly reflects ¥0.37bn of FX gains and a ¥0.55bn gain on sale of investment securities. Accordingly, the early outperformance does not translate one-for-one into recurring full-year earnings upside. Management forecasts FY2027 revenue growth of 11.2% but operating income and ordinary income declines of 24.0% and 26.6%, respectively. This outlook implies that Q1 margins are likely not assumed to persist through the full year, highlighting sensitivity to pricing, mix, input costs, foreign exchange, and production utilization. R&D spending of ¥0.89bn is rising, but 2.2% of sales is low relative to the alert threshold and should be monitored against the pace of product and process innovation required in specialty chemical markets.

Financial Health

The balance sheet is conservatively capitalized, with total equity of ¥105.39bn representing 65.8% of total assets. The current ratio of 232.4% and quick ratio of 155.4% indicate ample short-term liquidity, with no current-ratio warning. Working capital was ¥49.81bn. Debt-to-equity was 0.52x and debt-to-capital was 18.7%, both comfortably within conservative solvency ranges; there is no D/E warning. Interest-bearing debt totaled ¥24.24bn, consisting of ¥9.74bn in short-term loans and ¥14.50bn in long-term loans. Cash and deposits of ¥15.16bn covered short-term loans by 1.56x, mitigating near-term refinancing pressure. Nevertheless, the short-term debt ratio was 40.2%, marginally above the 40% refinancing-risk alert threshold. The root cause is that short-term loans increased ¥6.76bn YoY, or 227.1%, while long-term loans remained unchanged at ¥14.50bn. This structure is manageable given strong current liquidity, but increases dependence on rolling short-dated facilities and raises sensitivity to funding-market conditions and borrowing costs. Inventories increased ¥8.27bn YoY, or 40.0%, to ¥28.98bn, materially outpacing revenue growth. Receivables were ¥32.57bn and inventories accounted for 18.1% of total assets, tying a significant share of capital into the operating cycle. Net defined benefit liability was limited at ¥0.75bn, while intangible assets were 2.8% of total assets, indicating no material intangible-asset concentration. Property, plant and equipment represented 38.3% of assets, consistent with a capital-intensive chemical manufacturing base.

Notable B/S Changes

Short-term loans: +¥6.76bn (+227.1%) to ¥9.74bn - increased short-term funding reliance; cash covers 1.56x of short-term loans, but the short-term debt ratio reached 40.2% and marginally triggered the refinancing-risk alert. Inventories: +¥8.27bn (+40.0%) to ¥28.98bn - inventory growth materially exceeded revenue growth and is consistent with the elevated inventory-days and cash-conversion-cycle alerts; monitor demand realization and valuation risk. Treasury stock: +¥3.86bn (+91.7%, becoming less negative) to -¥0.35bn - a substantial reduction in the treasury-stock deduction increased reported equity support and should be considered when assessing per-share capital allocation trends. Buildings and structures: +¥9.57bn (+65.2%) to ¥23.98bn - alongside a sharp reduction in construction in progress, this indicates a meaningful shift in the fixed-asset base that warrants monitoring for utilization and depreciation effects. Machinery and equipment: +¥17.35bn (+218.5%) to ¥25.30bn - a substantial increase in productive assets raises the importance of capacity utilization and returns on manufacturing investment. Construction in progress: -¥25.74bn (-90.8%) to ¥2.62bn - the reduction alongside higher completed fixed assets indicates a major movement from projects under construction into the operating asset base.

Cash Flow Quality

Working-capital efficiency is the principal earnings-quality issue. Annualized receivable days of 74 exceed the 60-day quality-alert threshold, indicating slower cash collection than the stated benchmark. Annualized inventory days of 100 exceed the 90-day warning threshold. The additional inventory-days alert of 85 days also exceeds its 60-day benchmark, reinforcing that inventory intensity is elevated under either reported alert methodology. The annualized cash conversion cycle of 123 days exceeds the 120-day warning threshold. The root cause is the combination of elevated receivables and inventory relative to the quarterly sales base, alongside the ¥8.27bn YoY inventory build. For a chemical manufacturer, this may reflect inventory accumulated for demand growth, customer delivery commitments, or input procurement, but it heightens the risk of slower cash conversion, inventory valuation pressure, and weaker cash generation if volumes or pricing soften. The impact on the investment thesis is that reported margin improvement should be assessed alongside the conversion of receivables and finished goods into cash. Finished goods were ¥28.98bn, raw materials were ¥4.54bn, and work in process was ¥0.60bn. The positive earnings trend is not accompanied here by reported operating cash flow or free cash flow figures, so cash conversion and internally funded capital-allocation capacity cannot be quantified from the available figures.

Dividend Sustainability

The FY2027 dividend forecast is ¥70 per share. Against forecast EPS of ¥124.46, the implied dividend-only payout ratio is 56.2%. This is below the 60% sustainability reference point and indicates that the planned dividend is covered by forecast earnings. Q1 EPS was ¥50.53, equivalent to 40.6% of full-year forecast EPS, providing a strong initial earnings base for the planned distribution. The company has announced a revised dividend policy incorporating DOE, which may make shareholder distributions more closely linked to balance-sheet equity as well as annual earnings. Total equity was ¥105.39bn and book value per share was ¥1,636.10, providing substantial capital support for the policy. The sustainability consideration is less the stated earnings payout and more the elevated working-capital requirement, particularly inventory and receivables, which may constrain cash available for distributions if the operating cycle lengthens.

Risk Assessment

Business risks include Working-capital risk is elevated: annualized DSO of 74 days, DIO of 100 days, and a 123-day cash conversion cycle each breach stated warning levels. The likely issue is capital being absorbed by customer receivables and inventories; the impact would be weaker cash conversion and greater exposure to demand or pricing reversals., Inventory risk is material for a chemical manufacturer. Inventories rose 40.0% YoY to ¥28.98bn, while the inventory-days alerts of 100 days and 85 days are both above their respective benchmarks. A downturn in customer demand, falling raw-material prices, or product-mix changes could create valuation, write-down, or margin pressure., Functional Materials remains subject to asset-utilization and product-demand risk. The segment recorded an impairment loss related to polyethylene powder and gas-product manufacturing equipment at the Chiba plant, indicating that certain production assets have faced recoverability pressure., Foreign-exchange exposure affected Q1 profitability, with FX gains of ¥0.37bn equal to approximately 10.8% of operating income. A reversal in currency conditions would reduce ordinary-income support., R&D intensity of 2.2% is below the 3% quality-alert threshold. For specialty and functional materials, sustained underinvestment could weaken product differentiation and long-term competitiveness, although the appropriate level depends on the maturity of each product category..

Financial risks include The short-term debt ratio of 40.2% marginally exceeds the 40% refinancing-risk alert threshold. Short-term loans increased 227.1% YoY to ¥9.74bn, increasing reliance on refinancing despite adequate cash coverage., The capital structure remains sound overall, with D/E of 0.52x, debt/capital of 18.7%, a current ratio of 232.4%, and interest coverage of 46.65x. Therefore, the refinancing risk is a maturity-profile concern rather than a balance-sheet solvency concern., Net income included a ¥0.55bn gain on sale of investment securities, representing 16.8% of reported quarterly net income. This raises volatility risk in extrapolating Q1 net-profit growth..

Key concerns include Priority one is normalization of receivable days, inventory days, and the cash conversion cycle as revenue grows., Priority two is confirmation that Absorbent Resins margin expansion and Functional Materials' profit rebound are operationally sustainable rather than predominantly driven by temporary pricing, mix, FX, or lower impairment charges., Priority three is the divergence between strong Q1 profit progress and a full-year forecast that calls for operating and ordinary-income declines despite revenue growth., Priority four is the use of a larger short-term borrowing balance to fund operations and investment needs..

Investment Implications

Key takeaways include Q1 showed strong operating leverage: revenue increased 13.6%, operating income increased 47.5%, and operating margin expanded approximately 195bp to 8.5%., Absorbent Resins is the core earnings engine, contributing approximately 78% of consolidated operating income, while Functional Materials delivered the largest margin recovery., Annualized ROE of 12.4% is solid and is supported primarily by improved net margin rather than aggressive leverage., Liquidity and solvency are strong, but the operating cycle is inefficient, with 74-day DSO, 100-day DIO, and a 123-day cash conversion cycle., Q1 net income was supported by a ¥0.55bn gain on sale of investment securities and ¥0.37bn of FX gains, requiring caution in annualizing bottom-line growth., The ¥70 FY2027 dividend forecast implies a 56.2% earnings payout ratio and is supported by forecast earnings and a substantial equity base..

Metrics to watch include Absorbent Resins segment revenue growth, segment margin, and contribution to consolidated operating income, Functional Materials profitability and any further impairment charges at the Chiba plant, Inventory balance, inventory days, and any inventory valuation losses, Receivable days and cash conversion cycle, Short-term loan balance, refinancing mix, and cash-to-short-term-debt coverage, FX gains or losses relative to operating income, Progress against the FY2027 operating-income forecast, particularly after the Q1 31.4% progress rate, R&D intensity and the relationship between R&D spending and product development outcomes.

Regarding relative positioning, The company combines a sound balance sheet, strong interest coverage, and a good annualized ROE profile with a capital-intensive manufacturing footprint. Its operating margin of 8.5% is within the stated good range but remains below the 15% excellent benchmark. Relative strength lies in conservative leverage and Q1 operating leverage; relative weakness lies in elevated working-capital intensity, low reported R&D intensity, and the non-recurring contribution to quarterly net income.